Öztekin Algül

1.3k total citations
67 papers, 1.1k citations indexed

About

Öztekin Algül is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Öztekin Algül has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Organic Chemistry, 25 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Öztekin Algül's work include Synthesis and biological activity (42 papers), Synthesis and Biological Evaluation (14 papers) and Computational Drug Discovery Methods (14 papers). Öztekin Algül is often cited by papers focused on Synthesis and biological activity (42 papers), Synthesis and Biological Evaluation (14 papers) and Computational Drug Discovery Methods (14 papers). Öztekin Algül collaborates with scholars based in Türkiye, Germany and United States. Öztekin Algül's co-authors include Serdar Burmaoğlu, Hakan Arslan, Mehmet Abdullah Alagöz, İlhami Gülçın, Fatma Gümüş, Burak Kuzu, Nizami Duran, Furkan Ayaz, Ali Yılmaz and Aylin Döğen and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Öztekin Algül

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Öztekin Algül Türkiye 19 723 301 183 138 135 67 1.1k
Akranth Marella India 13 1.0k 1.4× 310 1.0× 141 0.8× 133 1.0× 54 0.4× 21 1.3k
Mohemmed Faraz Khan India 17 1.2k 1.7× 413 1.4× 146 0.8× 195 1.4× 35 0.3× 30 1.6k
İlkay Küçükgüzel Türkiye 22 1.2k 1.7× 360 1.2× 223 1.2× 135 1.0× 50 0.4× 57 1.7k
İrfan Koca Türkiye 16 782 1.1× 250 0.8× 95 0.5× 164 1.2× 211 1.6× 51 1.1k
Sanjiv Kumar India 19 857 1.2× 284 0.9× 74 0.4× 150 1.1× 22 0.2× 35 1.2k
Shamsuzzaman India 16 635 0.9× 319 1.1× 111 0.6× 65 0.5× 25 0.2× 40 1.0k
Sandhya Bawa India 19 1.6k 2.2× 543 1.8× 164 0.9× 144 1.0× 39 0.3× 51 2.0k
Mohamed M. Abdalla Egypt 26 1.5k 2.1× 348 1.2× 227 1.2× 116 0.8× 25 0.2× 89 1.8k
Paola Vicini Italy 21 1.8k 2.5× 575 1.9× 216 1.2× 138 1.0× 97 0.7× 63 2.3k
Maria Gabriella Vigorita Italy 21 1.3k 1.8× 553 1.8× 163 0.9× 62 0.4× 53 0.4× 43 1.8k

Countries citing papers authored by Öztekin Algül

Since Specialization
Citations

This map shows the geographic impact of Öztekin Algül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Öztekin Algül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Öztekin Algül more than expected).

Fields of papers citing papers by Öztekin Algül

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Öztekin Algül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Öztekin Algül. The network helps show where Öztekin Algül may publish in the future.

Co-authorship network of co-authors of Öztekin Algül

This figure shows the co-authorship network connecting the top 25 collaborators of Öztekin Algül. A scholar is included among the top collaborators of Öztekin Algül based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Öztekin Algül. Öztekin Algül is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Algül, Öztekin, et al.. (2025). The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies. Chemical Biology & Drug Design. 105(1). e70045–e70045. 7 indexed citations
2.
Kuzu, Burak, Derya Yetkin, Ceylan Hepokur, & Öztekin Algül. (2025). Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells. Chemical Biology & Drug Design. 105(3). e70078–e70078. 1 indexed citations
5.
Algül, Öztekin, Burak Mete, Burçin Türkmenoğlu, et al.. (2024). Substituted bisbenzimidazole derivatives as multiple targeting agents to treat Alzheimer's disease, diabetes, and microbial infections. Journal of Molecular Structure. 1323. 140800–140800. 2 indexed citations
6.
Türkmenoğlu, Burçin, et al.. (2024). Synthesis and evaluation of di‐heterocyclic benzazole compounds as potential antibacterial and anti‐biofilm agents against Staphylococcus aureus. Chemical Biology & Drug Design. 104(2). e14601–e14601. 2 indexed citations
7.
Demir, Yeliz, et al.. (2024). Investigation of Some Metabolic Enzyme Inhibition Properties of Novel Chalcone‐Cu Complexes. ChemistrySelect. 9(27). 4 indexed citations
8.
Hepokur, Ceylan, et al.. (2024). From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors. ChemMedChem. 19(16). e202400108–e202400108. 2 indexed citations
9.
Alagöz, Mehmet Abdullah, et al.. (2023). Deep learning approach to the discovery of novel bisbenzazole derivatives for antimicrobial effect. Journal of Molecular Structure. 1295. 136668–136668. 9 indexed citations
11.
Yıldırım, Metin, Mehmet Abdullah Alagöz, Derya Yetkin, et al.. (2023). N-(benzazol-2-yl)-2-substituted phenylacetamide derivatives: Design, synthesis and biological evaluation against MCF7 breast cancer cell line. Journal of Molecular Structure. 1285. 135513–135513. 2 indexed citations
12.
Sağlamtaş, Rüya, et al.. (2022). Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies. Computational Biology and Chemistry. 100. 107748–107748. 21 indexed citations
13.
Gambacorta, Nicola, et al.. (2021). Synthesis and biological evaluation of 3,5‐diaryl‐pyrazole derivatives as potential antiprostate cancer agents. Archiv der Pharmazie. 354(12). e2100225–e2100225. 7 indexed citations
14.
Burmaoğlu, Serdar, Gözde Yalçın, Ceylan Hepokur, et al.. (2021). Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents. Bioorganic Chemistry. 111. 104882–104882. 16 indexed citations
15.
Alagöz, Mehmet Abdullah, et al.. (2020). Bisbenzoxazole Derivatives: Design, Synthesis,in VitroAntimicrobial, Antiproliferative Activity, and Molecular Docking Studies. Polycyclic aromatic compounds. 42(6). 3103–3123. 9 indexed citations
16.
Gi̇ray, Elife Sultan, et al.. (2020). Revisit to the synthesis of 1,2,3,4-tetrasubstituted pyrrole derivatives in lactic acid media as a green solvent and catalyst. Molecular Diversity. 25(4). 2321–2338. 6 indexed citations
17.
Burmaoğlu, Serdar, Şeyda Özcan, Sevgi Balcıoğlu, et al.. (2019). Synthesis, biological evaluation and molecular docking studies of bis-chalcone derivatives as xanthine oxidase inhibitors and anticancer agents. Bioorganic Chemistry. 91. 103149–103149. 59 indexed citations
18.
Burmaoğlu, Serdar, et al.. (2016). Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Bioorganic & Medicinal Chemistry Letters. 26(13). 3172–3176. 52 indexed citations
19.
Algül, Öztekin, et al.. (2012). Apoptotic and Anti-Angiogenic Effects of Benzimidazole Compounds: Relationship with Oxidative Stress Mediated Ischemia/Reperfusion Injury in Rat Hind Limb. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 11(3). 267–275. 10 indexed citations
20.
Algül, Öztekin & Berrın Özçelık. (2005). Synthesis, Characterization and Genotoxicity of Platinum(II)Complexes With Subtituted Benzimidazole Ligands. DergiPark (Istanbul University). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026